Market

Balance Sheet

You can view the Balance Sheet for the last 5 years.

BALANCE SHEET

GlaxoSmithKline Pharmaceuticals Ltd.

GO
Market Cap. ( ₹ in Cr. ) 55936.18 P/BV 33.44 Book Value ( ₹ ) 98.74
52 Week High/Low ( ₹ ) 3516/1921 FV/ML 10/1 P/E(X) 60.13
Book Closure 30/05/2025 EPS ( ₹ ) 54.91 Div Yield (%) 1.64
(₹ in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
No. of Equity Shares (in Lacs)1694.061694.061694.061694.061694.06
      
EQUITIES AND LIABILITIES     
SHAREHOLDER'S FUNDS     
Equity Share Capital169.41169.41169.41169.41169.41
Total Share Capital169.41169.41169.41169.41169.41
      
Reserves and Surplus1781.901617.241573.542493.551308.85
Total Reserves and Surplus1781.901617.241573.542493.551308.85
Employees Stock Options0.00-9.01-1.680.000.00
Total Shareholders Funds1951.311777.641741.272662.961478.26
      
NON-CURRENT LIABILITIES     
Other Long Term Liabilities2.496.574.149.6822.31
Long Term Provisions249.11247.46254.80262.21259.50
Total Non-Current Liabilities251.60254.03258.94271.89281.81
      
CURRENT LIABILITIES     
Short Term Borrowings0.000.000.000.000.02
Trade Payables708.25625.41427.79570.55466.13
Other Current Liabilities780.50506.02480.79799.90613.80
Short Term Provisions416.41393.52417.79327.98274.62
Total Current Liabilities1905.151524.951326.371698.431354.58
      
Total Capital And Liabilities4108.073556.623326.584633.283114.65
      
ASSETS     
NON-CURRENT ASSETS     
Tangible Assets270.32297.72295.87296.15343.55
Intangible Assets13.3323.5534.0934.5043.36
Capital Work-In-Progress14.3213.9320.3130.5013.21
Fixed Assets297.97335.20350.27361.15400.12
Deferred Tax Assets [Net]140.87146.31133.55113.15103.13
Long Term Loans And Advances0.000.0070.00190.000.00
Other Non-Current Assets259.34276.68278.50260.95408.76
Total Non-Current Assets698.18758.20832.32925.25912.01
      
      
CURRENT ASSETS     
Current Investments1118.25813.22518.29365.590.00
Inventories481.74525.05459.97534.70546.70
Trade Receivables292.55222.06192.38205.24215.60
Cash And Cash Equivalents1403.521063.221155.932484.511157.96
OtherCurrentAssets113.83174.87167.70118.00282.37
Total Current Assets3409.882798.422494.263708.032202.64
      
Total Assets4108.073556.623326.584633.283114.65
      
OTHER INFORMATION     
      
CONTINGENT LIABILITIES, COMMITMENTS     
Contingent Liabilities490.50387.14361.80368.97498.50
      
BONUS DETAILS     
Bonus Equity Share Capital125.39125.39125.39125.39125.39
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
No. of Equity Shares (in Lacs)1694.06
  
EQUITIES AND LIABILITIES 
SHAREHOLDER'S FUNDS 
Equity Share Capital169.41
Total Share Capital169.41
Reserves and Surplus1781.90
Total Reserves and Surplus1781.90
Employees Stock Options0.00
Total Shareholders Funds1951.31
NON-CURRENT LIABILITIES 
Other Long Term Liabilities2.49
Long Term Provisions249.11
Total Non-Current Liabilities251.60
CURRENT LIABILITIES 
Short Term Borrowings0.00
Trade Payables708.25
Other Current Liabilities780.50
Short Term Provisions416.41
Total Current Liabilities1905.15
Total Capital And Liabilities4108.07
ASSETS 
NON-CURRENT ASSETS 
Tangible Assets270.32
Intangible Assets13.33
Capital Work-In-Progress14.32
Fixed Assets297.97
Deferred Tax Assets [Net]140.87
Long Term Loans And Advances0.00
Other Non-Current Assets259.34
Total Non-Current Assets698.18
CURRENT ASSETS 
Current Investments1118.25
Inventories481.74
Trade Receivables292.55
Cash And Cash Equivalents1403.52
OtherCurrentAssets113.83
Total Current Assets3409.88
Total Assets4108.07
OTHER INFORMATION 
CONTINGENT LIABILITIES, COMMITMENTS 
Contingent Liabilities490.50
BONUS DETAILS 
Bonus Equity Share Capital125.39